PMCA for Ultrasensitive Detection of Prions and to Study Disease Biology
Overview
Authors
Affiliations
The emergence of a novel class of infectious agent composed exclusively of a misfolded protein (termed prions) has been a challenge in modern biomedicine. Despite similarities on the behavior of prions with respect to conventional pathogens, the many uncertainties regarding the biology and virulence of prions make them a worrisome paradigm. Since prions do not contain nucleic acids and rely on a very different way of replication and spreading, it was necessary to invent a novel technology to study them. In this article, we provide an overview of such a technology, termed protein misfolding cyclic amplification (PMCA), and summarize its many applications to detect prions and understand prion biology.
Screening of Anti-Prion Compounds Using the Protein Misfolding Cyclic Amplification Technology.
Pritzkow S, Schauer I, Tupaki-Sreepurna A, Morales R, Soto C Biomolecules. 2024; 14(9).
PMID: 39334879 PMC: 11430292. DOI: 10.3390/biom14091113.
Baranova S, Mosko T, Bruzova M, Haldiman T, Kim C, Safar J Sci Rep. 2024; 14(1):6294.
PMID: 38491063 PMC: 10943125. DOI: 10.1038/s41598-024-56789-6.
α-Synuclein seed amplification technology for Parkinson's disease and related synucleinopathies.
Soto C Trends Biotechnol. 2024; 42(7):829-841.
PMID: 38395703 PMC: 11223967. DOI: 10.1016/j.tibtech.2024.01.007.
Detection of prions in the urine of patients affected by sporadic Creutzfeldt-Jakob disease.
Pritzkow S, Ramirez F, Lyon A, Schulz P, Appleby B, Moda F Ann Clin Transl Neurol. 2023; 10(12):2316-2323.
PMID: 37814583 PMC: 10723238. DOI: 10.1002/acn3.51919.
New developments in prion disease research.
Gilch S, Schatzl H Cell Tissue Res. 2023; 392(1):1-5.
PMID: 36918429 DOI: 10.1007/s00441-023-03760-y.